The University of Chicago Header Logo

Connection

Derek Wainwright to Melanoma, Experimental

Back to Details
This is a "connection" page, showing publications Derek Wainwright has written about Melanoma, Experimental.
Derek Wainwright
Connection Strength
0.169
Melanoma, Experimental
  1. Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy. J Hematol Oncol. 2020 06 09; 13(1):74.
    View in: PubMed
    Score: 0.169
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.